Clinical and epidemiological aspects of patients infected with SARS-CoV-2 variants: a case-control study

Authors

DOI:

https://doi.org/10.33448/rsd-v11i3.26792

Keywords:

Case-control Studies; Signs and Symptoms; Virus infection, COVID-19.

Abstract

Objective: To compare the clinical outcomes of patients infected with SARS-CoV-2 variants with patients infected with the original strain. Methods: This is a case control study comparing cases of COVID-19 patients infected with SARS-CoV-2 variants of concern identified by genomic sequencing, with a control group of 62 patients randomly selected from a COVID-19 database of patients diagnosed prior to the emergence of these variants. Findings: In the 40 patients infected with variants, the predominant (52.5%) was P.1 variant. The variant group presented more arthralgia (p=0.015), hyporexia (p=0.006), nausea/vomiting (p=0.048), and mental confusion (p=0.029), the last not identified in the control group. There were no significant differences in comorbidities or demographic data between the groups. Severe disease, according to the WHO Clinical Progression Scale, was identified only in those infected with the variants, as well as high-flow oxygen therapy and ICU admission (p=0.05). The two deaths reported in the study were in patients infected with the variants. Conclusions: The worst outcomes were observed in the group infected with SARS-CoV-2 variants, although no significant differences in comorbidities or demographics date were observed between the groups.

References

Abbud, A., & Castilho, E. A. (2022). A call for a more comprehensive SARS-CoV-2 sequence database for Brazil. The Lancet Regional Health - Americas, 5(November 2021), 100095. https://doi.org/10.1016/j.lana.2021.100095

Aleem, A., Akbar Samad, A. B., & Slenker, A. K. (2021). Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19). In StatPearls. http://www.ncbi.nlm.nih.gov/pubmed/34033342

Castro, M. C., Kim, S., Barberia, L., Ribeiro, A. F., Gurzenda, S., Ribeiro, K. B., Abbott, E., Blossom, J., Rache, B., & Singer, B. H. (2021). Spatiotemporal pattern of COVID-19 spread in Brazil. Science, 372(6544), 821–826. https://doi.org/10.1126/science.abh1558

Chakraborty, C., Sharma, A. R., Bhattacharya, M., Agoramoorthy, G., & Lee, S.-S. (2021). Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants. MBio, 12(4). https://doi.org/10.1128/mBio.01140-21

Correia, A. O., Feitosa, P. W. G., Moreira, J. L. de S., Nogueira, S. Á. R., Fonseca, R. B., & Nobre, M. E. P. (2020). Neurological manifestations of COVID-19 and other coronaviruses: A systematic review. Neurology, Psychiatry and Brain Research, 37, 27–32. https://doi.org/10.1016/j.npbr.2020.05.008

Espíndola, O. de M., Siqueira, M., Soares, C. N., Lima, M. A. S. D. de, Leite, A. C. C. B., Araujo, A. Q. C., Brandão, C. O., & Silva, M. T. T. (2020). Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid. International Journal of Infectious Diseases, 96, 567–569. https://doi.org/10.1016/j.ijid.2020.05.123

Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., Candido, D. da S., Mishra, S., Crispim, M. A. E., Sales, F. C. S., Hawryluk, I., McCrone, J. T., Hulswit, R. J. G., Franco, L. A. M., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. M., Ferreira, G. M., Silva, C. A. M., Manuli, E. R., … Sabino, E. C. (2021). Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science, 372(6544), 815–821. https://doi.org/10.1126/science.abh2644

Graham, M. S., Sudre, C. H., May, A., Antonelli, M., Murray, B., Varsavsky, T., Kläser, K., Canas, L. S., Molteni, E., Modat, M., Drew, D. A., Nguyen, L. H., Polidori, L., Selvachandran, S., Hu, C., Capdevila, J., Hammers, A., Chan, A. T., Wolf, J., … Gunson, R. N. (2021). Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study. The Lancet Public Health, 6(5), e335–e345. https://doi.org/10.1016/S2468-2667(21)00055-4

Guo, S., Liu, K., & Zheng, J. (2021). The Genetic Variant of SARS-CoV-2: Would it matter for Controlling the Devastating Pandemic? International Journal of Biological Sciences, 17(6), 1476–1485. https://doi.org/10.7150/ijbs.59137

Hemmer, C. J., Löbermann, M., & Reisinger, E. C. (2021). COVID-19: Epidemiologie und Mutationen. Der Radiologe, 61(10), 880–887. https://doi.org/10.1007/s00117-021-00909-0

Lamarca, A. P., de Almeida, L. G. P., da Silva Francisco Junior, R., Cavalcante, L., Machado, D. T., Brustolini, O., Gerber, A. L., Guimarães, A. P. de C., Policarpo, C., da de Oliveira Silva, G., Boullosa, L. T., de Souza, I. V., de Carvalho, E. M., Ribeiro, M. S., Carvalho, S., da Silva, F. D., de Oliveira Garcia, M. H., de Souza, L. M., Da Silva, C. G., … Vasconcelos, A. T. R. (2021). Genomic Surveillance Tracks the First Community Outbreak of the SARS-CoV-2 Delta (B.1.617.2) Variant in Brazil. Journal of Virology. https://doi.org/10.1128/JVI.01228-21

Leung, C. (2020). Clinical features of deaths in the novel coronavirus epidemic in China. Reviews in Medical Virology, 30(3). https://doi.org/10.1002/rmv.2103

Marshall, J. C., Murthy, S., Diaz, J., Adhikari, N. K., Angus, D. C., Arabi, Y. M., Baillie, K., Bauer, M., Berry, S., Blackwood, B., Bonten, M., Bozza, F., Brunkhorst, F., Cheng, A., Clarke, M., Dat, V. Q., de Jong, M., Denholm, J., Derde, L., … Zhang, J. (2020). A minimal common outcome measure set for COVID-19 clinical research. The Lancet Infectious Diseases, 20(8), e192–e197. https://doi.org/10.1016/S1473-3099(20)30483-7

Maury, A., Lyoubi, A., Peiffer-Smadja, N., de Broucker, T., & Meppiel, E. (2021). Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Revue Neurologique, 177(1–2), 51–64. https://doi.org/10.1016/j.neurol.2020.10.001

Ministério da Saúde, (BRASIL). (2020). Vigitel Brasil 2019 : vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico : (Ministério da Saúde (ed.)).

Naveca, F. G., Nascimento, V., de Souza, V. C., Corado, A. de L., Nascimento, F., Silva, G., Costa, Á., Duarte, D., Pessoa, K., Mejía, M., Brandão, M. J., Jesus, M., Gonçalves, L., da Costa, C. F., Sampaio, V., Barros, D., Silva, M., Mattos, T., Pontes, G., … Bello, G. (2021). COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence. Nature Medicine, 27(7), 1230–1238. https://doi.org/10.1038/s41591-021-01378-7

Ong, S. W. X., Young, B. E., & Lye, D. C. (2021). Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes. The Lancet Infectious Diseases, 21(9), 1195–1197. https://doi.org/10.1016/S1473-3099(21)00201-2

Tang, J. W., Tambyah, P. A., & Hui, D. S. (2021). Emergence of a new SARS-CoV-2 variant in the UK. Journal of Infection, 82(4), e27–e28. https://doi.org/10.1016/j.jinf.2020.12.024

Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021). The biological and clinical significance of emerging SARS-CoV-2 variants. Nature Reviews Genetics, 22(12), 757–773. https://doi.org/10.1038/s41576-021-00408-x

Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., Mlisana, K., von Gottberg, A., Walaza, S., Allam, M., Ismail, A., Mohale, T., Glass, A. J., Engelbrecht, S., Van Zyl, G., … de Oliveira, T. (2021). Detection of a SARS-CoV-2 variant of concern in South Africa. Nature, 592(7854), 438–443. https://doi.org/10.1038/s41586-021-03402-9

Zeiser, F. A., Donida, B., da Costa, C. A., Ramos, G. de O., Scherer, J. N., Barcellos, N. T., Alegretti, A. P., Ikeda, M. L. R., Müller, A. P. W. C., Bohn, H. C., Santos, I., Boni, L., Antunes, R. S., Righi, R. da R., & Rigo, S. J. (2022). First and second COVID-19 waves in Brazil: A cross-sectional study of patients’ characteristics related to hospitalization and in-hospital mortality. The Lancet Regional Health - Americas, 6(November 2021), 100107. https://doi.org/10.1016/j.lana.2021.100107

Downloads

Published

03/03/2022

How to Cite

ALBUQUERQUE, A. M. S. .; SANTOS, J. V. G. .; TORRES, S. A. .; SANTOS, C. N. O. .; MAGALHÃES, L. S. .; SANTOS, C. A. dos .; CAVALCANTE, T. F. .; GOIS FILHO, P. G. de; CORREIA FILHO, D. .; SILVA, J. S. da .; JESUS, A. R. de; MELO, E. V. de .; ALMEIDA, R. P. de . Clinical and epidemiological aspects of patients infected with SARS-CoV-2 variants: a case-control study. Research, Society and Development, [S. l.], v. 11, n. 3, p. e44511326792, 2022. DOI: 10.33448/rsd-v11i3.26792. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/26792. Acesso em: 16 jun. 2024.

Issue

Section

Health Sciences